Teneligliptin hydrobromide hydrate is a dipeptidyl peptidase-4 inhibitor. It is indicated for the treatment of type 2 diabetes. Tenelia is available as tablet for oral use, containing 20 mg of free Teneligliptin, and the recommended dose is 20 mg (40 mg if insufficient) once daily for adults.
Teneligliptin Hydrobromide Hydrate contains not less than 98.0 per cent and not more than 102.0 per cent of C22H30N6OS, 1/2 HBr, xH2O, calculated on the anhydrous basis.